A National Academies of Sciences, Engineering, and Medicine report recommends that the attempt to revise the Common Rule start over again, NPR reports.
A trial by Tesaro indicates that its PARP inhibitor can limit ovarian cancer growth in patients with and without BRCA mutations.
In Nature this week: methylation analysis methods compared, and more.
An event today is to highlight cancer research efforts and bolster the Cancer Moonshot Initiative, according to the Associated Press.
Harvard researchers find mostly skin bacteria on Boston subway trains and platforms.
In Cell this week: assay to uncover variants that modulate gene expression, immune regulatory role for lincRNA-EPS, and more.
Researchers look into why healthy people seek DNA sequencing, the Wall Street Journal reports.
A genotyping issue leads to two retractions and some wasted lab time, Retraction Watch reports.
The Genomics Analysis Centre in the UK is now the Earlham Institute, Business Weekly reports.
In PNAS this week: effect of genomic selection on cows; Arabidopsis thaliana assembly using short reads, long reads, and linkage data; and more.
Travelers can quickly pick up antibiotic-resistance genes, according to Dutch researchers.
The Wall Street Journal reports that many newly minted biotech millionaires are being cautious with their wealth.
In a Q&A with Scientific American, a stem cell researcher describes how gene editing could be used to treat or prevent disease.
In PLOS this week: developmental genome rearrangements in sea lampreys, Zika virus detected in saliva and urine, and more.
Researchers in the UK react to the vote there to leave the European Union.
The US Food and Drug Administration tracked a recent multi-state Listeria outbreak using whole-genome sequencing.
Companies vie to manage genomic data, the Economist reports.
In Science this week: proof-reading reverse transcriptase, call for integration of engineering and physical sciences with biomedical science, and more.
Researchers uncover genetic variants that could be behind a number of unexplained sudden cardiac deaths.
A couple is using their sequencing results to guide their healthcare, diet, and more.
France is to invest €670 million in personalized medicine centers, according to RFI.
In Nature this week: maximum-depth sequencing to detect rare variants, and more.
The FDA has just approved the first clinical trial for a DNA-based vaccine for the Zika virus, Technology Review reports.
A federal safety panel gives the go-ahead to a study that plans to use CRISPR to alter patients' immune cells to treat their cancer.
Researchers find that certain genes have increased expression after death, New Scientist reports.
A researcher recounts in Science how she got her career off the ground.
Bitesize Bio offers some word of wisdom for designing a new lab.
A study finds that some women choose science majors later in their college careers.
The US National Labor Relations Board rules that graduate assistants have the right to unionize.